Menkes Disease Epidemiology Insights & Trends

• Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A. The minimum birth prevalence for Menkes disease is believed to be 1 in 34,810 live male births, and potentially as high as 1 in 8,664 live male births, based on recent genome-based ascertainment
• Patients with Menkes disease are born with the inability to absorb dietary copper and subsequently have impaired copper transport across the blood-brain barrier.
• Menkes disease is a devastating disorder, with death usually occuring between 6 months and 3 years of age.

Menkes Disease Epidemiology Forecast in the 7MM

• 2025 Prevalent of Menkes Disease: ~XX
• 2036 Projected Menkes Disease Prevalent Cases: ~XX
• Menkes Disease Growth Rate (2026–2036): ~XX% CAGR

DelveInsight's ‘Menkes Disease Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Menkes disease, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Menkes Disease Understanding and Diagnosis Algorithm

Menkes Disease Overview

Menkes disease is a serious neuropsychiatric complication of advanced liver disease and portosystemic shunting, characterized by impaired brain function resulting from the accumulation of neurotoxins, particularly ammonia, that are inadequately cleared by the diseased liver. The condition presents as a spectrum ranging from subtle cognitive impairment and sleep disturbances to confusion, disorientation, personality changes, asterixis (flapping tremor), and, in severe cases, coma. HE is commonly associated with liver cirrhosis and significantly increases morbidity, mortality, hospitalization rates, and healthcare burden.

Further details are provided in the report...

Menkes Disease Diagnosis

Diagnosis of Menkes disease is based on clinical presentation, biochemical findings, and genetic confirmation. Laboratory evaluation commonly reveals low serum copper and ceruloplasmin levels, while molecular testing identifies pathogenic variants in the ATP7A gene. Neuroimaging may demonstrate cerebral atrophy, delayed myelination, and vascular abnormalities associated with copper deficiency. Early diagnosis is critical because therapeutic outcomes are highly dependent on treatment initiation before significant neurological damage occurs. Increasing use of next-generation sequencing and expanded genetic testing panels is improving diagnostic accuracy and facilitating earlier detection of affected infants.

Further details are provided in the report...

Menkes Disease Epidemiology

Key Findings from Menkes Disease Epidemiological Analysis and Forecast

• The US (~60%) accounted for the highest diagnosed prevalent cases of Menkes disease.
• France recorded the highest number of diagnosed prevalent cases of Menkes disease among the EU4 and the UK, followed by Germany.
• It is more common in boys, represent more than 90% of affected children.
• Menkes disease is more prevalent in males (~95%) than in females.
• The incidence of Menkes disease is about 1 in 35,000 live male births. The majority of diagnosed infants are male; however, MD may still occur in females, related to unusual genetic circumstances.

Scope of the Menkes Disease Epidemiology Report

• The report covers a segment of a descriptive overview of Menkes disease, explaining their causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Menkes Disease Epidemiology Report Insights

Menkes Disease Patient Population Forecast

Menkes Disease Epidemiology Report Key Strengths

• Epidemiology-based (Epi-based) Bottom-up Forecasting
• 11-year Forecast
• Patient Burden Trends (by geography)

Stay ahead of emerging opportunities with DelveInsight's Menkes Disease Market Insights, Epidemiology, and Market Forecast–2036 report for strategic decision-making.

FAQs

• What are the disease risks, burdens, and unmet needs of Menkes disease? What will be the growth opportunities across the 7MM concerning the patient population with Menkes disease?
• What is the historical and forecasted Menkes disease patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy Menkes Disease Epidemiology Forecast Report

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.